NSC 207895(XI-006)可以抑制MDM4和MDMX的表达,激活p53,同时导致促凋亡(apoptosis)基因(如PUMA、BAX和PIG3)表达增加。
别名:XI-006
NSC-207895 (XI-006) is a derivative of nitrobenzofuroxan and an anticancer agent with an EC50 of 1 μM. NSC-207895 (XI-006) is a highly electrophilic compound known to have both antitumor and mutagenic activities. NSC-207895 (XI-006) may lead to the damage of DNA that inhibits the growth of tumors. NSC-207895 (XI-006) strikingly prevented the expression of MDMX which is a p53-binding protein and modulate the activities and stabilities of p53. NSC-207895 (XI-006) is less toxic and reduced the activities of MDMX promoter in a dose-dependent manner. Moreover,NSC-207895 (XI-006) possibly decreased the expression of MDMX via suppressing MDMX transcription. However, NSC-207895 (XI-006) induced the expression of MDM2 which is also a p53 downstream gene, despite to a less extent. In addition, NSC-207895 (XI-006) also upregulated the expression of p53 in MCF-7 cells that led to increased expression of proapoptotic genes including PUMA, BAX, as well as PIG3. Notably, NSC-207895 (XI-006), also called a small-molecule p53 activator, gives rise to MCF-7 cells to experience apoptosis and decrease the viability of cancer cells along with nutlin-3a, which dissociated the MDM2-p53 complex.
体外实验* | |
---|---|
细胞系 | MCF-7 cell |
方法 | Treating MCF-7 cells with dimethyl sulfoxide (DMSO), nutlin-3a, or NSC-207895 are permeabilized with cold 70% ethanol overnight, and staining with a solution containing 50 μg/mL propidium iodide and 20 μg/mL RNase A at 37°C for 20 minutes. And then subjected the cells to flow cytometry analysis. Using the FlowJo software to calculate percentages of cells in each cell cycle phase. For terminal deoxynucleotidyl transferase–mediated dUTP nick end labeling (TUNEL) staining,according to the manufacturer's protocol, MCF-7 cells treated with the NSC-207895 for 2 days are fixed with 4% paraformadelhyde for 1 hour, and then subjected to dUTP labeling using In Situ Cell Death Detection Kit TMR Red . For quantitation, choose at least 300 cells randomly and count the numbers of TUNEL-positive cells . |
浓度 | 1-10 μM |
处理时间 | 2 days |
*上述方法来自公开文献,仅供相同目的实验参考。如实验目的、材料、方法不同,请参考其他文献。
体内实验* | |
---|---|
动物模型 | |
配制 | |
剂量 | |
给药处理 |
*上述方法来自公开文献,仅供相同目的实验参考。如实验目的、材料、方法不同,请参考其他文献。
分子量 | 279.25 |
分子式 | C11H13N5O4 |
CAS号 | 58131-57-0 |
溶解性(25°C) | DMSO |
储存条件 |
粉末型式 -20°C 3年;4°C 2年 溶于溶剂 -80°C 6个月;-20°C 1个月 |
运输方式 | 冰袋运输,根据产品的不同,可能会有相应调整。 |
*下述溶液配置方法仅为基于分子量计算出的理论值。不同产品在配置溶液前,需考虑其在不同溶剂中的溶解度限制。
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 3.581 mL | 17.9051 mL | 35.8102 mL |
5 mM | 0.7162 mL | 3.581 mL | 7.162 mL |
10 mM | 0.3581 mL | 1.7905 mL | 3.581 mL |
小鼠 | 大鼠 | 兔 | 豚鼠 | 仓鼠 | 狗 | |
重量 (kg) | 0.02 | 0.15 | 1.8 | 0.4 | 0.08 | 10 |
体表面积 (m2) | 0.007 | 0.025 | 0.15 | 0.05 | 0.02 | 0.5 |
Km 系数 | 3 | 6 | 12 | 8 | 5 | 20 |
动物 A (mg/kg) = 动物 B (mg/kg) × | 动物 B的Km系数 |
动物 A的Km系数 |
例如,依据体表面积折算法,将化合物用于小鼠的剂量20 mg/kg 换算成大鼠的剂量,需要将20 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到化合物用于大鼠的等效剂量为10 mg/kg。
其他相关的Mdm2产品 |
---|
MMRi64
MMRi64 破坏 Mdm2-MdmX 相互作用。 |
MeOIstPyrd
MeOIstPyrd 是一种抗皮肤癌化合物。 |
MDM2/XIAP-IN-3
MDM2/XIAP-IN-3 是一种 MDM2/XIAP 双重抑制剂。 |
UNP-6457
UNP-6457 是一种有效的 MDM2-p53 相互作用抑制剂,其 IC50 值为 8.9 nM。 |
YL93
YL93 是 MDM2/4 的双重抑制剂 (Ki=0.64 μM, MDM4; 1.1 nM, MDM2)。 |
产品仅供科学研究或药证申报的用途使用,不为任何个人或者非科研性质的其他用途提供服务。
Copyright © 2010-2022 AbMole版权所有 沪ICP备16047849号 沪公网安备 31011502012228号